Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin LymphomaYing Shang1, Hongyu Zhao2, Daqi Li21Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China
2Central Hospital Affiliated to Shandong First Medical University, Shandong, China
Keywords: Relapsed/refractory aggressive B-cell lymphoma, Orelabrutinib, Lenalidomide, R-mini CDOP
Relaps/Refrakter Agresif B-hücre Non-Hodgkin Lenfomada Orelabrutinib ve Lenalidomidle Birlikte R-Mini CDOP Kullanımının Etki ve GüvenilirliğiYing Shang1, Hongyu Zhao2, Daqi Li21Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China
2Central Hospital Affiliated to Shandong First Medical University, Shandong, China
Anahtar Kelimeler: Relpas/refrakter agresif B-hücre lenfoma, Orelabrutinib, Lenalidomid, R-mini CDOP
Ying Shang, Hongyu Zhao, Daqi Li. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Hematol. 2023; 40(4): 284-285
Corresponding Author: Daqi Li, China |
|